| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | $1.3750 | -3.17% | $219.39M | $504.71K | |
| $2.7900 | +2.01% | $217.47M | $1.62K | |
MFM Aberdeen Municipal Income Fund | $5.2700 | -0.19% | $217.47M | $187.37K | |
CHCI Comstock Holding Companies, Inc. Class A | $20.8150 | -1.58% | $217.46M | $38.22K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | $10.0000 | +0.60% | $217.43M | $11.00 | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | $5.8200 | -0.34% | $217.14M | $45.11K | |
EXFY Expensify, Inc. Class A Common Stock | $2.3800 | +0.00% | $217.02M | $417.55K | |
| $62.8400 | -3.05% | $216.79M | $18.29K | |
IIF Morgan Stanley India Investment Fund, Inc. | $22.8100 | -1.17% | $216.64M | $30.78K | |
VYGR Voyager Therapeutics, Inc. Common Stock | $3.3800 | -3.70% | $216.27M | $319.71K | |
MITT TPG Mortgage Investment Trust, Inc. | $6.7800 | -0.29% | $216.26M | $216.24K | |
| $1.5400 | -2.53% | $215.73M | $1.01M | |
PEPG PepGen Inc. Common Stock | $3.2000 | +2.89% | $215.39M | $1.89M | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2.6500 | -0.75% | $215.12M | $881.58K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | $10.5100 | -0.10% | $214.97M | $50.17K | |
